Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Capital/Financing Update 2023

Jul 27, 2023

61700_rns_2023-07-27_1370343d-575b-4777-8180-a20aa9c80df0.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

July 27, 2023

==> picture [105 x 46] intentionally omitted <==

THRU ONLINE FILING

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB

Sub: Credit Rating for bank facilities and commercial paper

This is to inform you that India Ratings & Research (A Fitch Group Company) has reviewed and assigned the following ratings to Company’s working capital limit, long term loan and commercial paper :

Instrument Type Maturity Size of Issue Rating/Outlook Rating
Date (Million) Action
Fund/Non-fund INR 21,000 IND AA+/Stable/IND Affirmed
based working (increased from A1+
capital limit INR17,500)
INR 6,730 IND AA+/Stable Affirmed
Long-term loan FY28 (increased from
INR 4,000)
Commercial Paper(CP)* Up to 365days INR 2,500 IND A1+ Assigned
(CP)* Up to 365days INR 500 IND A1+ Affirmed

*The CP is not carved out of Ipca’s fund-based working capital limits.

This is for your information and record.

Thanking you

Yours faithfully For Ipca Laboratories Limited

HARISH PANDURANG KAMATH Digitally signed by HARISH PANDURANG KAMATH DN: c=IN, o=PERSONAL, 2.5.4.20=3e5648a57390d9262997da3de9051643bfb87e352b111402af42d207e52e25c6, postalCode=400063, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, cn=HARISH PANDURANG KAMATH Date: 2023.07.27 16:08:33 +05'30'

Harish P. Kamath

Corporate Counsel & Company Secretary

==> picture [443 x 69] intentionally omitted <==